Skip to main content

How can we help you?

Sybren de Beurs Partner

Sybren de Beurs is a partner at the Corporate M&A practice of NautaDutilh's Amsterdam office. He focusses his practice primarily on public and private cross-border deals and venture capital funding and has a sector specific focus on the tech and life sciences industry. Sybren develops multifaceted bespoke solutions to client challenges by leveraging a wide breadth of experience in M&A, a pragmatic approach and a solid business sense.

Sybren has been involved in assisting:

  • Mylan's USD 22 bn merger with Pfizer division Upjohn
  • NASDAQ on its auction sale of BWise
  • Arvelle Therapeutics Series A financing up to USD and inlicensing from SK Biopharmaceuticals with an upfront payment of USD 100 million with a future milestone potential of up to USD 430
  • Binck Bank on Saxo Bank's recommended public offer
  • Docdata on the disposal of its entire business by a coordinated simultaneous sale of both its businesses valued around EUR 200 million
  • Incyte on its EUR 300 million PIPE transaction and collaboration agreement with Merus
  • FairPhone as company counsel and on its Series C financing of around EUR 20 million
  • Siemens Healthineers on its strategical Series A investment in Screenpoint Medical
  • J&J Innovation on its investment in Biogeneration Ventures Fund
  • VarmX on its Series A investment round
  • Groupe Casino on the spin-off of Cnova's Brazilian ecommerce business towards its JV partner Via Varejo and related exit offer to Cnova's minority shareholders
  • Blackline on its USD 31 million acquisition of Runbook

Cookie notice

Our website only uses cookies when you play video content. Video content is streamed from YouTube, YouTube is a Google service. Our website does not use tracking cookies and/or third party cookies when you do not play video content. Please read the privacy/cookie policy for more information.